First in Human
Showing 26 - 50 of >10,000
Lymphoma Trial (BYON4228 + Rituximab)
Not yet recruiting
- Lymphoma
- BYON4228 + Rituximab
- (no location specified)
Feb 20, 2023
Osteochondrodysplasia Trial in Newark (SAR442501, Placebo)
Completed
- Osteochondrodysplasia
- SAR442501
- Placebo
-
Newark, New JerseyInvestigational site
Apr 26, 2023
Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))
Not yet recruiting
- Alopecia Areata
- OR-101 (Single ascending dose)
- +3 more
-
Randwick, New South Wales, AustraliaSCIENTIA Clinical Research Ltd
Sep 13, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Aneurysms Saccular, Aneurysm, Ruptured, Aneurysm Trial in Medellin (SEAL Device)
Recruiting
- Aneurysms Saccular
- +2 more
- SEAL Device
-
Medellin, Antioquia, ColombiaClinicas Las Americas
Jan 9, 2023
Healthy Volunteers, Mild to Moderate Psoriasis Trial in Manchester (Placebo, AX-202)
Recruiting
- Healthy Volunteers
- Mild to Moderate Psoriasis
- Placebo
- AX-202
-
Manchester, Wythenshawe, United KingdomMedicines Evaluation Unit
Jul 19, 2023
PTSD, Alzheimer, Brain Diseases Trial in Liège (Fluoroethylnormemantine (FENM))
Not yet recruiting
- PTSD
- +5 more
- Fluoroethylnormemantine (FENM)
-
Liège, BelgiumCHU of Liège - Clinical Pharmacology Unit
Jun 23, 2023
EGFR Mutant Advanced NSCLC Trial (BBT-207)
Not yet recruiting
- EGFR Mutant Advanced Non-Small Cell Lung Cancer
- (no location specified)
Jun 16, 2023
Cholera, Cholera Vaccine Toxicity Trial in Boston (PanChol)
Recruiting
- Cholera
- Cholera Vaccine Toxicity
- PanChol
-
Boston, MassachusettsBrigham and Women's Hospital Vaccine Unit
Dec 11, 2022
Multi Vessel Coronary Artery Disease Trial in Leuven, Vilnius (CABG)
Enrolling by invitation
- Multi Vessel Coronary Artery Disease
- CABG
-
Leuven, Belgium
- +1 more
Jan 24, 2023
Standard Operating Procedures for Anti-HPV Antibody Detection in
Completed
- Human Papilloma Virus Infection
- First-void urine collection
- Blood draw
-
Wilrijk, Antwerp, Belgiumuniversity of Antwerp - centre for the evaluation of vaccination
Nov 7, 2022
Neuronal Ceroid Lipofuscinosis Type 2 Trial in London (RGX-381)
Not yet recruiting
- Neuronal Ceroid Lipofuscinosis Type 2
- RGX-381
-
London, United KingdomGreater Ormond Street Hospital
Mar 17, 2023
Advanced or Metastatic Solid Tumors Trial in Birtinya, Frankston (KGX101- Cohort 1, KGX101- Cohort 2, KGX101- Cohort 3)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- KGX101- Cohort 1
- +7 more
-
Birtinya, Queensland, Australia
- +1 more
Oct 3, 2023
Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5 Trial in Barranquilla, Bogotá, Cali
Active, not recruiting
- Chronic Kidney Disease stage3
- +3 more
- PAVmed PortIO™ Intraosseous Infusion System
-
Barranquilla, Atlantico, Colombia
- +3 more
Sep 7, 2023
Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)
Recruiting
- Triple Negative Breast Cancer
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Nov 13, 2023
Locally Advanced Solid Tumor, Metastatic Tumor Trial in San Antonio (TST003)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Tumor
-
San Antonio, TexasNEXT Oncology
Feb 15, 2023
Alpha 1-Antitrypsin Deficiency Trial in Tempe (VX-634, Placebo)
Recruiting
- Alpha 1-Antitrypsin Deficiency
- VX-634
- Placebo
-
Tempe, ArizonaCelerion - Tempe
Nov 9, 2022
Systemic Lupus Erythematosus Trial (RO7507062, Tocilizumab)
Not yet recruiting
- Systemic Lupus Erythematosus
- (no location specified)
Apr 19, 2023
Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural
Not yet recruiting
- Rabies Virus Infection
- Natural full human monoclonal antibody CBB 1 injection
- +3 more
-
Kunming, Yunnan, ChinaThe First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023
Phenylketonuria Trial in Melbourne (JNT-517 Suspension, Placebo Suspension, JNT-517 Tablet)
Recruiting
- Phenylketonuria
- JNT-517 Suspension
- +3 more
-
Melbourne, Melbourne VIC, AustraliaNucleus Network Melbourne
Mar 10, 2023
Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)
Not yet recruiting
- Hematological Malignancy
- Solid Tumor
- OT-A201
- +4 more
- (no location specified)
Apr 24, 2023
Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an
Recruiting
- Metastatic Solid Tumor Cancer
- Dose escalation, first-in-human phase I clinical trial with an Expansion phase
-
Caen, France
- +2 more
Oct 11, 2022
Cytomegalovirus Infections Trial in Manchester (SPYVAC01)
Not yet recruiting
- Cytomegalovirus Infections
- SPYVAC01
-
Manchester, United KingdomMedicines Evaluation Unit
Nov 20, 2023